Introducing Fierce Biotech’s 2026 Fierce 15: Freya Therapeutics

Constructive Bio Founder and Chief Scientific Officer Professor Jason Chin wins 2026 Heinrich Wieland Prize

LEO Pharma Bolsters Rare Skin Disease Focus Through Acquisition of Replay Gene Therapy Platform

Why Do Mind-Altering Drugs Make People Feel Better?

Voices of biotech leaders: Colleen Acosta

Delix Therapeutics Announces Positive Efficacy Data for DLX-001 (Zalsupindole) and FDA Clearance of Phase II Trial Design Featuring At‑Home Administration

Nature biotechnology editor’s pick: Constructive Bio

Constructive Bio joins Ellison Institute to find new medicines

VedaBio Announces Strategic Agreement with Siemens Healthineers and Series A Extension, Totaling Up to $25 Million

VedaBio Accelerating Amplification-Free Syndromic POC MDx With Additional CRISPR IP

VedaBio Expands CRISPR-Based Molecular Detection Platform With Mammoth Biosciences’ Technology

The Microbiome May Hold the Key to IVF Success